Physician profile
Brett Driver
NPI 1295326031
$2,262.71
in general payments reported to CMS, 2019-2025
34 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $188 · 2022: $524 · 2023: $690 · 2024: $588 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,551.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $349.26 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $230.11 | 2022-2025 | |
| Exact Sciences Corporation | $174.55 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $152.26 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $138.36 | 2022 | |
| Amgen INC. | $118.21 | 2021-2024 | Repatha, Otezla |
| Pfizer INC. | $117.60 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.38 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $68.65 | 2022-2024 | Gardasil, Vaqta, Gardasil 9 |
| Dexcom, INC. | $62.06 | 2023-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $59.01 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $52.49 | 2024 | Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $51.84 | 2022-2025 | Arexvy, Shingrix, Bexsero |
| Spr Therapeutics, INC | $50.51 | 2024 | Sprint Pns System |
| Boston Scientific Corporation | $49.60 | 2023 | Watchman Access System |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $46.67 | 2021 | |
| Inari Medical, INC. | $45.66 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biohaven Pharmaceuticals, INC. | $39.47 | 2021 | |
| Cranial Technologies, INC | $34.36 | 2025 | Doc Band |
| Antares Pharma, INC. | $33.87 | 2022 | |
| Medtronic, INC. | $32.22 | 2021-2022 | |
| Inspire Medical Systems, INC. | $23.59 | 2023 | Inspire |
| Astellas Pharma US INC | $23.21 | 2025 | Veozah |
| Siemens Medical Solutions USA, INC. | $22.95 | 2022 | |
| Acella Pharmaceuticals, LLC | $22.83 | 2024 | NP Thyroid 60 |
| Dynavax Technologies Corporation | $19.29 | 2025 | Heplisav-B |
| Itamar Medical INC | $18.80 | 2023 | Watchpatone |
| Axsome Therapeutics, INC. | $18.79 | 2025 | Auvelity |
| Philips North America LLC | $16.52 | 2024 | (Ck7) Extended Holter |
| Lundbeck LLC | $15.93 | 2023 | Vyepti |
| Angiodynamics, INC. | $14.65 | 2025 | Smart Port Ct |
| Si-Bone, INC. | $14.61 | 2021 | |
| Acerus Pharmaceuticals Corporation | $13.92 | 2021 | |
| Amarin Pharma, INC. | $13.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Driver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.